AstraZeneca Most cancers Drug: AstraZeneca will get CDSCO nod for drug to
March 3, 20230
India Information: NEW DELHI: Drug agency AstraZeneca India on Friday stated it has obtained approval from the home drug regulator to market a drug to deal with biliary trac.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Comment here